InfuSystem Q2 FY26 net income rises 24% to $3.2 million; revenue increases 2.6% to $36.9 million - INFU News | RalliesInfuSystem Q2 FY26 net income rises 24% to $3.2 million; revenue increases 2.6% to $36.9 million
I
INFU• Quarterly results and outlook
- InfuSystem posted GAAP net income of $3.2 million, or $0.15 per diluted share, up from $2.6 million, or $0.12 per diluted share.
- Net revenues rose 2.6% to $36.9 million, with Patient Services up 15% to $24.8 million, offset by Device Solutions down 16% to $12.1 million.
- Gross profit increased 8% to $21.4 million, lifting gross margin 2.8 percentage points to 58%.
- Non-GAAP adjusted EBITDA climbed 8% to $8.6 million, with adjusted EBITDA margin up 1.1 percentage points to 23.4%.
- CEO Carrie Lachance cited Oncology surpassing $20 million in quarterly revenue, reaffirming 2026 pro forma net revenue growth of 6% to 8%.
•
